http://www.americancryostem.com 
American CryoStem Corporation (OTCQB: CRYO) is a pioneer in the fields of Regenerative and Personalized Medicine, American CryoStem is a developer, marketer and global licensor of patented adipose tissue-based cellular technologies and related proprietary services with a focus on clinical processing, commercial bio-banking and application development for adipose (fat) tissue and autologous adipose-derived regenerative cells (ADRCs). The Company maintains a strategic portfolio of intellectual property and patent applications that form its Adipose Tissue Processing Platform, which supports and promotes a growing pipeline of biologic products and processes, clinical services and international licensing opportunities. Through its ACS Laboratories division, the Company operates an FDA registered, cGMP compliant human tissue processing, cryo-storage, cell culture and differentiation media development facility in Mount Laurel, New Jersey.
For more information, please visit www.americancryostem.com and www.acslaboratories.com.
Corporate Lab Facility in New Jersey 
Adipose Tissue Processing Platform American CryoStem has invested heavily over the past five years to develop and bring to market our proprietary, validated, turn-key FDA registered laboratory for Adipose Tissue Processing. The clinical processing platform enables us to cryopreserve an individual’s adipose tissue (fat) or process it into the Stromal Vascular Fraction (SVF), which contains adipose-derived regenerative cells (ADRCs) growth factors and other regenerative cells, including white blood cells, endothelial cells, smooth muscle cells, pericytes, fibroblasts and pre-adipocytes, among others. The Company’s Platform is centered on enabling affordable, end-to-end, clinical collection, processing, tracking and storage of adipose tissue and ADRCs. Stored tissue may be retrieved for immediate use in cosmetic and reconstructive surgery of the face, hands, breasts and buttocks; further processing and delivery of a cellular sample for use in topical or orthopedic applications; or processing and expansion for direct or IV injection for cell therapy treatments.
In addition to implementing strategies to drive rapid, exponential growth of its Cellular Processing and Storage Services, American CryoStem is also actively engaged in the production of a proprietary line of anti-aging, autologous skin care products; the marketing and licensing of its proprietary, patented tissue culture media products; and the identification and pursuit of partnering and licensing opportunities that will fully capitalize on the strengths of our IP and turnkey Adipose Tissue Processing Platform.
Branded, Proprietary Products, Services & Technologies 
CELLECT™ Cellular Collection and Storage Service -- a clinical solution for physicians to acepticitally collect and deliver tissue samples utilizing proprietary and patent-pending methods and materials. The service creates an unbreakable “chain of custody” between physician/client and ACS Laboratories. The Cellect service is monitored in real-time and assures the highest cell viability upon laboratory receipt. Our collection/processing/storage pricing model provides for an initial collection and processing fee ranging from $750 to $2500, depending upon the volume of tissue and the desired processing and testing services required. The annual storage fee charged to an individual is based upon the type of material being
cryo-preserved (adipose tissue or ADRCs), the total volume and the storage configuration. The minimum storage fee is $200 per year. There are currently over 35 medical practices, and counting, across the United States now offering the Company’s adipose tissue and ADRC collection, processing and storage services. 
ATGRAFT™ Adipose Tissue Storage Service – a clinical solution for physicians to provide their patients with the highest quality fat transfer and body sculpting procedures and storage technologies. The ATGRAFT Service permits individual atients to benefit by using their own stored adipose tissue as a natural biocompatible filler for procedures without the trauma of further liposuctions. ATGRAFT procedures include breast augmentation, buttocks enhancement or volume corrections in the hands, face and neck. 
American CryoStem is also engaged in marketing, selling and licensing our patented human-based tissue culture media products under the trademark ACSelerate™. The most widely used medium today for storing and growing stem cell cultures for in vitro diagnostics and research use is fetal bovine serum, raising questions about utilizing animals for the medium as well as generating debates relating to potential cross-contamination. We have pioneered and patented a new cell culture medium for growing human stromal cells (including all cells found in human skin, fat and other connective tissue) that is animal product free and suitable for human clinical and therapeutic uses.
More specifically, ACS Laboratories has been granted patent number 7,989,205 “Cell Culture Media, Kits and Methods of Use” (August 2, 2011). The granted claims include “A cell culture medium for clinical growth of human adipose stromal cells for human clinical and therapeutic applications.” The granted claims also include variations for cellular differentiation of adipose derived stem cells into osteoblasts (bone), chondrocytes (cartilage), adipocytes (fat), neural cells, smooth muscles cells in both HSA (clinical) grade and FBS (research) grade. This patent covers both non-GMP research grades and GMP clinical grades suitable for cell culture of adipose-derived mesenchymal stem cells intended for use in humans. Company Service Overview video http://www.youtube.com/watch?v=Uco2ON-59yU Financial Information:
http://www.americancryostem.com/investors/ 
http://bcove.me/f2kwg5yf (Interview From Access Hollywood of Suzanne Somers Speaking about how Her Own Adipose Tissue was able to Regrow Her Breast after Cancer/Mastectomy